文献速递临床试验与 GCP流行病学与生物统计

IMMPACT推荐结局指标与评估工具在灼口综合征随机对照试验中的应用:国际德尔菲调查方案

IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol.
PubMed 文献 · Trials · 2020-08-12

本研究旨在为灼口综合征(BMS)随机对照试验(RCT)制定核心结局指标集(COS),采用COMET推荐方法,基于IMMPACT共识和既往系统评价选择问卷结局指标,邀请国际临床医生和研究者参与多轮德尔菲调查,并召开共识会议确定纳入COS的结局,最终形成解释性文件,以期提高未来RCT质量、减少结局报告异质性并促进数据合成。

要点

  • BMS的RCT结局指标繁多且异质,尚无BMS特异性COS被采纳和验证。
  • 将采用COMET方法通过国际德尔菲调查和共识会议制定BMS的COS。
  • COS有望改善未来BMS的RCT质量并促进系统评价与meta分析的数据合成。

核心结论

  • 为BMS制定基于IMMPACT结局域及其评估工具的COS,可减少结局报告异质性并提升证据质量。

研究设计与样本

  • 采用COMET推荐方法制定BMS特异性COS,并已注册(http://www.comet-initiative.org/studies/details/1357)。
  • 邀请国际临床医生和研究者参与多轮德尔菲调查,随后召开共识会议批准纳入COS的结局。
  • 问卷结局指标的选择参考IMMPACT共识和该联盟既往的BMS的RCT系统评价。

主要发现

  • 现有文献中BMS的RCT疗效结局指标数量多且多样。
  • 尚无BMS特异性COS被采纳和验证,而IMMPACT核心结局域已为慢性疼痛RCT开发。

关键数值与推荐

  • 将确定IMMPACT标准化结局域及其评估工具在BMS临床试验和临床实践中的共识。
  • 最终COS解释性文件将包含德尔菲轮次和共识会议确定的所有结局和测量工具。

临床怎么用

  • 未来BMS的RCT应测量和报告COS规定的结局域和测量工具。
  • COS有助于系统评价和meta分析更稳健地合成BMS管理干预数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A core outcome set (COS) represents the agreed minimum set of domains and measurement instruments that should be measured and reported in any clinical trial for a given condition. In BMS randomized controlled trials (RCTs), the outcomes identified in the existing literature regarding the efficacy of therapeutic interventions are numerous and diverse. Although the standardized IMMPACT core outcome domains has been developed for measurement of outcomes in chronic pain RCTs, no BMS-specific COS have been adopted and validated. With the evolving landscape of BMS management end points and the development of new therapies, a consensus on a COS for use in future BMS trials is paramount to reduce heterogeneity in outcome reporting. The aim of this study was to reach a consensus for adopting the standardized Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) outcome domains, and their tools of assessment, for burning mouth syndrome (BMS) clinical trials and clinical practice. METHODS: A BMS-specific COS will be developed using the method recommended by the Core Outcome Measures in Effective Trials (COMET) initiative (Registration: http://www.comet-initiative.org/studies/details/1357 ). Selection of questionnaire outcome measures was informed by the IMMPACT consensus and previous systematic review of RCTs in BMS conducted by the consortium. An international group of clinicians and researchers will be invited to participate in several rounds of a Delphi survey. A consensus meeting will be held with the objective of ratifying the outcomes for inclusion in the COS. A finalized COS explanatory document will be drafted, including all outcomes and measurements as determined by the Delphi rounds and consensus meeting. DISCUSSION: A COS for the management of BMS will improve the quality of future RCTs, reduce outcome reporting heterogeneity, and facilitate more vigorous data synthesis of management interventions for systematic reviews and meta-analysis. This would ensure enhanced quality evidence for clinical management of the condition.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Carey B, Farag AM, Nasri-Heir C, et al. IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol. Trials. 2020. PMID: 32787910. doi:10.1186/s13063-020-04640-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。